Rankings
▼
Calendar
▼
CYCN Q1 2018 Earnings Report — Cyclerion Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
Cyclerion Therapeutics, Inc.
CYCN
Q1 2018 Earnings
Reported March 30, 2018
Quarter Comparison
Revenue
Operating Income
EPS (Diluted)
Free Cash Flow
Metric
Q1 2018
Q4 2017
Q1 2017
QoQ Change
YoY Change
Revenue
$0
$0
—
—
—
Op. Income
-$25M
-$28M
—
8.6%
—
EPS (Diluted)
$-18.52
$-20.19
—
8.3%
—
Free Cash Flow
-$27M
—
—
—
—
marketcaparena.com
Income Statement
Item
Amount
REVENUE
$0
Cost of Revenue
$0
GROSS PROFIT
$0
R&D Expenses
$22M
Selling & Marketing
$0
General & Administrative
$4M
SG&A Expenses
$4M
Other Expenses
$0
Operating Expenses
$25M
Cost & Expenses
$25M
OPERATING INCOME
-$25M
Interest Income
$0
Interest Expense
$0
Other Income/Expenses
$0
INCOME BEFORE TAX
-$25M
Income Tax Expense
$0
Net Income from Continuing Ops
-$25M
Net Income from Discontinued Ops
$0
Other Adjustments
$0
NET INCOME
-$25M
Net Income Deductions
$0
BOTTOM LINE NET INCOME
-$25M
D&A
$356.0K
EBIT
-$25M
EBITDA
-$25M
EPS
-$19
EPS Diluted
-$19
marketcaparena.com
Cash Flow Statement
Item
Amount
Net Income
-$25M
Depreciation & Amortization
$356.0K
Stock-Based Compensation
$3M
Deferred Income Tax
$0
Other Non-Cash Items
$0
Change in Working Capital
-$4M
OPERATING CASH FLOW
-$26M
Capital Expenditure
-$162.0K
Acquisitions (Net)
$0
Purchases of Investments
$0
Sales/Maturities of Investments
$0
Other Investing Activities
$0
NET CASH FROM INVESTING
-$162.0K
Net Debt Issuance
$0
Common Stock Repurchased
$0
Common Dividends Paid
$0
Other Financing Activities
$27M
NET CASH FROM FINANCING
$27M
FREE CASH FLOW
-$27M
Net Change in Cash
$0
marketcaparena.com
← FY 2018
CYCN Overview
Q2 2018 →